Australia, Aug. 1 -- Gyre Therapeutics Inc., owns the trademark (2627058) for 'G GYRE THERAPEUTICS' and 'TWIST & CAPSULE FORM LTR G' till Dec. 23, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases.] and 42 [Conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products development; research and development in the pharmaceutical and bi...